SCHEMBL1633413

SCHEMBL1633413

NC(=O)c1cccc(Oc2cccc3cnc(Nc4ccc(S(N)(=O)=O)cc4)nc23)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA9 Q16790 1/20 0.47
CDK2 P24941 4/20 0.46
CCNA2 P20248 2/20 0.46
SYK P43405 3/20 0.45
IKBKB O14920 4/20 0.44
CDK1 P06493 3/20 0.43
GSK3B P49841 2/20 0.43
EGFR P00533 2/20 0.43
CDC7 O00311 1/20 0.43
PLK4 O00444 1/20 0.43
CHEK1 O14757 1/20 0.43
AURKA O14965 1/20 0.43
DCLK1 O15075 1/20 0.43
PDPK1 O15530 1/20 0.43
DAPK3 O43293 1/20 0.43
JAK2 O60674 1/20 0.43
ROCK2 O75116 1/20 0.43
MAP4K4 O95819 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1634182 0.86 CA1 (0.60) CA1CA2CA9CDK2IKBKB
SCHEMBL1633814 0.85 EGFR (0.55) CA1CA2CA9CDK2CCNA2
SCHEMBL1633419 0.85 NTRK1 (0.44) CA1CA2CA9CDK2CCNA2
SCHEMBL1633262 0.82 IKBKB (0.49) CA1CA2CA9CDK2CCNA2
SCHEMBL1633411 0.81 MTOR (0.50) CA1CA2CA9CDK2CCNA2
SCHEMBL1633446 0.81 IKBKB (0.56) CA1CA2CA9CDK2IKBKB
SCHEMBL1634688 0.81 RXFP1 (0.45) CA1CA2CA9CDK2SYK
SCHEMBL1634190 0.80 IKBKB (0.53) CA1CA2CA9CDK2CCNA2
SCHEMBL1632432 0.80 CYP1A2 (0.48) CA1CA2CA9CDK2CCNA2
SCHEMBL1633821 0.80 STK4 (0.52) CA1CA2CA9CDK2IKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed